K. Marcseková, B. Wegener, S. Doye
FULL PAPER
(t, J = 7.0 Hz, 3 H), 1.29–1.49 (m, 4 H), 2.55–2.71 (m, 2 H), 2.76–
2.90 (m, 3 H), 7.14–7.22 (m, 3 H), 7.32 (d, J = 7.5 Hz, 1 H) ppm.
13C NMR (75 MHz, DEPT, CDCl3): δ = 14.3 (CH3), 15.6 (CH3),
1584, 1488, 1466, 1454, 1437, 11260, 1153, 1048, 1019, 783, 736,
696 cm–1. HRMS (%) calcd. [C14H21NO+] 219.1623, found
219.1544 (1); calcd. [C11H16NO+] 178.1232, found 178.1222 (25);
19.0 (CH2), 36.5 (CH2), 39.0 (CH2), 41.4 (CH2), 57.2 (CH), 126.6 calcd. [C8H9O+] 121.0653, found 121.0648 (71); calcd. [C6H12N+]
(CH), 127.5 (CH), 129.6 (CH), 131.6 (CH), 134.3 (C), 137.7 (C)
98.0970, found 98.0948 (100); calcd. [C4H10N+] 72.0813, found
72.0829 (66); calcd. [C4H8N+] 70.0657, found 70.0680 (38).
C14H21NO (219.3): C 76.67, H 9.65, N 6.39; found C 76.41, H 9.58,
N 6.59. 35b: 1H NMR (300 MHz, CDCl3): δ = –0.07 to 0.01 (m, 1
H), 0.04–0.12 (m, 1 H), 0.30–0.47 (m, 2 H), 0.51–0.60 (m, 1 H),
ppm. IR: ν = 3066, 2959, 2930, 2871, 1474, 1444, 1138, 1052, 1038,
˜
750, 682 cm–1. HRMS (%) calcd. [C13H19N37Cl+] 226.1177, found
226.1162 (2); calcd. [C13H19N35Cl+] 224.1206, found 224.1221 (5);
calcd. [C10H13N37Cl+] 184.0707, found 184.0704 (31); calcd.
[C10H13N35Cl+] 182.0737, found 182.0720 (98); calcd. [C7H637Cl+] 1.07 (t, J = 7.2 Hz, 3 H), 1.38–1.48 (m, 1 H), 1.64–1.73 (m, 1 H),
127.0129, found 127.0145 (17); calcd. [C7H635Cl+] 125.0158, found
125.0151 (50); calcd. [C6H14N+] 100.1120, found 100.1123 (100).
C13H20ClN (225.13): calcd. C 69.16, H 8.93, N 6.20; found C 69.51,
H 8.85, N 6.50.
2.49 (q, J = 7.1 Hz, 2 H), 3.67 (t, J = 6.9 Hz, 1 H), 3.80 (s, 3 H),
6.75 (d, J = 6.7 Hz, 1 H), 6.88 (s, 1 H), 6.90 (d, J = 6.8 Hz, 1 H),
7.19 (m, 1 H) ppm. 13C NMR (75 MHz, DEPT, CDCl3): δ = 4.1
(CH2), 4.6 (CH2), 8.3 (CH), 15.4 (CH3), 42.0 (CH2), 43.3 (CH2),
55.2 (CH3), 64.0 (CH), 112.1 (CH), 112.7 (CH), 119.7 (CH), 129.1
Amines 34a/34b: General procedure A was used to synthesize
amines 34a and 34b from 1-phenyl-2-cyclopropylethyne (15) and
ethylamine. After purification by flash chromatography (EtOAc/
MeOH, 2:1), amine 34a (333 mg, 1.76 mmol, 44%) and amine 34b
(CH), 146.5 (C), 159.7 (C) ppm. IR: ν = 2999, 2962, 2919, 2834,
˜
1599, 1486, 1465, 1260, 1047, 783, 701 cm–1. HRMS (%) calcd.
[C14H21NO+] 219.1623, found 219.1601 (2); calcd. [C14H20NO+]
218.1545, found 218.1559 (9); calcd. [C10H14NO+] 164.1075, found
164.1090 (100); calcd. [C10H12NO+] 162.0919, found 162.0923 (28);
calcd. [C9H10NO+] 148.0762, found 148.0790 (25); calcd. [C8H9O+]
121.0653, found 121.0631 (63); calcd. [C7H7+] 91.0548, found
91.0541 (29); calcd. [C6H5+] 77.0391, found 77.0421 (31).
1
(128 mg, 0.68 mmol, 14%) were obtained as colorless oils. 34a: H
NMR (300 MHz, CDCl3): δ = –0.08 to 0.00 (m, 1 H), 0.19–0.27
(m, 1 H), 0.36–0.45 (m, 1 H), 0.50–0.59 (m, 1 H), 0.67–0.78 (m, 1
H), 1.05 (t, J = 7.0 Hz, 3 H), 1.76 (br. s, 1 H), 1.94–2.01 (m, 1 H),
2.59 (dq, J = 11.4, 7.4 Hz, 1 H), 2.76–2.94 (m, 2 H), 7.19–7.31 (m,
5 H) ppm. 13C NMR (75 MHz, DEPT, CDCl3): δ = 2.2 (CH2), 4.8 Amines 39a/39b: General procedure B was used to synthesize
(CH2), 15.4 (CH3), 16.1 (CH), 42.0 (CH2), 65.0 (CH), 126.1 (CH), amines 39a and 39b from 4-methoxyphenylacetylene (36) and ethyl-
128.3 (CH), 129.4 (CH), 139.5 (C) ppm. IR: ν = 3076, 3063, 3026,
amine. After purification by flash chromatography (EtOAc/MeOH,
2:1), amine 39a (156 mg, 0.87 mmol, 22%) and amine 39b (150 mg,
0.84 mmol, 21%) were obtained as colorless oils. 39a: 1H NMR
(300 MHz, CDCl3): δ = 1.09 (t, J = 7.1 Hz, 3 H), 1.23 (br. s, 1 H),
˜
3000, 2967, 2922, 2869, 2848, 2805, 1603, 1494, 1453, 1141, 1031,
1019, 766, 699 cm–1. HRMS (%) calcd. [C13H19N+] 189.1517, found
189.1520 (1); calcd. [C12H16N+] 174.1283, found 174.1296 (2);
calcd. [C11H14N+] 160.1126, found 160.1094 (3); calcd. [C10H14N+] 2.66 (q, J = 7.1 Hz, 2 H), 2.75 (br. t, J = 7.1 Hz, 2 H), 2.85 (br. t,
148.1126, found 148.1133 (23); calcd. [C9H12N+] 134.0970, found
134.0957 (57); calcd. [C6H12N+] 98.0970, found 98.0988 (100);
calcd. [C7H7+] 91.0548, found 91.0540 (75). C13H19N (189.3): calcd.
C 82.48, H 10.12, N 7.40; found C 82.31, H 10.20, N 7.69. 34b: 1H
NMR (300 MHz, CDCl3): δ = –0.12 to –0.05 (m, 1 H), 0.00–0.07
(m, 1 H), 0.24–0.42 (m, 2 H), 0.45–0.55 (m, 1 H), 1.02 (t, J =
7.4 Hz, 3 H), 1.36–1.45 (m, 2 H), 1.60–1.68 (m, 1 H), 2.44 (dq, J
J = 6.5 Hz, 2 H), 3.78 (s, 3 H), 6.83 (d, J = 8.5 Hz, 2 H), 7.12 (d,
J = 8.7 Hz, 2 H) ppm. 13C NMR (75 MHz, DEPT, CDCl3): δ =
15.2 (CH3), 35.5 (CH2), 44.0 (CH2), 51.2 (CH), 55.2 (CH3), 113.9
(CH), 129.6 (CH), 132.2 (C), 158.0 (C) ppm. IR: ν = 2962, 2934,
˜
2834, 1612, 1513, 1464, 1300, 1247, 1178, 1129, 1038, 822 cm–1.
HRMS (%) calcd. [C11H17NO+] 179.1310, found 179.1314 (11);
calcd. [C10H14NO+] 164.1075, found 164.1080 (14); calcd.
= 8.9, 7.4 Hz, 2 H), 3.66 (t, J = 7.0 Hz, 1 H), 7.16–7.27 (m, 5 H) [C9H11O+] 135.0810, found 135.0784 (19); [C8H10O+] 122.0732,
ppm. 13C NMR (75 MHz, DEPT, CDCl3): δ = 4.1 (CH2), 4.6
found 122.0743 (90); [C7H7+] 91.0548, found 91.0563 (14); [C6H6
]
+
(CH2), 8.2 (CH), 15.4 (CH3), 42.0 (CH2), 43.4 (CH2), 64.0 (CH), 78.0470, found 78.0477 (15); [C6H5+] 77.0391, found 77.0397 (15).
126.8 (CH), 127.2 (CH), 128.2 (CH), 144.7 (C) ppm. IR: ν = 3076, C11H17NO (179.3): calcd. C 73.70, H 9.56, N 7.81; found C 73.28,
˜
1
3024, 2966, 2920, 2840, 1602, 1492, 1453, 1133, 1016, 753,
701 cm–1. HRMS (%) calcd. [C13H19N+] 189.1517, found 189.1498 = 7.1 Hz, 3 H), 1.35 (d, J = 6.6 Hz, 3 H), 2.43–2.56 (m, 2 H), 3.73
(1); calcd. [C9H13N+] 135.1048, found 135.0999 (96); calcd.
(q, J = 6.5 Hz, 1 H), 3.80 (s, 3 H), 6.86 (d, J = 8.7 Hz, 2 H), 7.23
[C9H12N+] 134.0970, found 134.0941 (100); calcd. [C7H8N+] (d, J = 8.5 Hz, 2 H) ppm. 13C NMR (75 MHz, DEPT, CDCl3): δ
H 9.28, N 7.88. 39b: H NMR (300 MHz, CDCl3): δ = 1.07 (t, J
106.0657, found 106.0639 (23); calcd. [C7H6N+] 104.0500, found
= 15.4 (CH3), 24.2 (CH3), 41.9 (CH2), 55.2 (CH3), 57.6 (CH), 113.7
104.0497 (19); calcd. [C7H7+] 91.0548, found 91.0549 (47); calcd. (CH), 127.5 (CH), 137.9 (C), 158.5 (C) ppm. IR: ν = 2962, 2834,
˜
[C6H7+] 79.0548, found 79.0564 (36). C13H19N (189.3): calcd. C 1611, 1512, 1464, 1301, 1244, 1177, 1037, 832, 557 cm–1. HRMS
82.48, H 10.12, N 7.40; found C 82.05, H 9.90, N 7.70.
(%) calcd. [C11H17NO+] 179.1310, found 179.1307 (4); calcd.
[C11H16NO+] 178.1232, found 178.1211 (3); calcd. [C10H14NO+]
164.1075, found 164.1069 (100); calcd. [C9H11O+] 135.0810, found
135.0793 (20). C11H17NO (179.3): calcd. C 73.70, H 9.56, N 7.81;
found C 74.11, H 9.92, N 7.33.
Amines 35a/35b: General procedure A was used to synthesize
amines 35a and 35b from 1-(3-methoxyphenyl)-2-cyclopropyle-
thyne (16) and ethylamine. After purification by flash chromatog-
raphy (EtOAc/MeOH, 10:1), amine 35a (412 mg, 1.88 mmol, 47%)
and amine 35b (88 mg, 0.40 mmol, 10%) were obtained as colorless
Amines 40a/40b: General procedure B was used to synthesize
oils. 35a: 1H NMR (300 MHz, CDCl3): δ = –0.05 to 0.03 (m, 1 H), amines 40a and 40b from 4-chlorophenylacetylene (37) and ethyl-
0.20–0.28 (m, 1 H), 0.37–0.46 (m, 1 H), 0.51–0.60 (m, 1 H), 0.66–
amine. After purification by flash chromatography (EtOAc/MeOH,
0.77 (m, 1 H), 1.04 (t, J = 7.0 Hz, 3 H), 1.40 (br. s, 1 H), 1.91–1.99 2:1), amine 40a (120 mg, 0.65 mmol, 16%) and a mixture of re-
(dd, J = 5.1 Hz, 3.6 Hz, 1 H), 2.53–2.59 (dd, J = 7.1 Hz, 4.1 Hz, 1
H), 2.70–2.86 (m, 3 H), 3.80 (s, 3 H), 6.75–6.76 (m, 3 H), 7.17–7.22
(m, 1 H) ppm. 13C NMR (75 MHz, DEPT, CDCl3): δ = 2.2 (CH2),
gioisomers 40a and 40b (191 mg, 1.04 mmol, 26%) were obtained
as colorless oils. 40a: H NMR (300 MHz, CDCl3): δ = 1.12 (t, J
= 7.1 Hz, 3 H), 2.01 (br. s, 1 H), 2.69 (q, J = 7.2 Hz, 2 H), 2.77–
1
5.1 (CH2), 15.7 (CH3), 16.4 (CH), 42.3 (CH2), 42.4 (CH2), 55.3 2.92 (m, 4 H), 7.15 (d, J = 8.4 Hz, 2 H), 7.28 (d, J = 8.4 Hz, 2 H)
(CH3), 65.0 (CH), 111.6 (CH), 115.3 (CH), 122.0 (CH), 129.4 (CH), ppm. 13C NMR (75 MHz, DEPT, CDCl3): δ = 15.0 (CH3), 35.6
141.3 (C), 159.8 (C) ppm. IR: ν = 2999, 2961, 2937, 2834, 1601, (CH2), 43.9 (CH2), 50.72 (CH2), 128.6 (CH), 130.0 (CH), 131.9 (C),
˜
4850
© 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2005, 4843–4851